Keto Lovers, Read This: New Study Says Your Diet Might Be Feeding Cancer

A new mouse study complicates the idea of the keto diet as a “miracle” cancer‑protective plan, showing it can suppress colon tumors while at the same time accelerating tumor growth in the small intestine, likely because chronic high-fat intake changes how intestinal cells burn fat and drives stem cells to divide more, which may increase cancer risk.

For years, the keto diet has been sold as a miracle—touted for weight loss, brain health, and even cancer protection—but a new study throws cold water on that simplistic narrative.

In genetically engineered mice, the same high‑fat, low‑carb keto plan that social media influencers swear by did something far more unsettling: it sped up tumor growth in one part of the intestine while slowing it down in another.

What The Researchers Actually Did

Researchers at MIT fed mice three different diets: a classic ketogenic diet, a standard control diet, and a high‑fat, high‑calorie "obesity" diet.

Despite staying lean, the keto‑fed mice developed small intestinal tumors at rates similar to—or worse than—those eating the obesity‑inducing diet, even as the keto diet continued to suppress tumor formation in the colon.

In other words, the same regimen hailed as protective for colon cancer might quietly be making another part of the gut more vulnerable.

The Twist: It Wasn't The Ketones

The most uncomfortable part of the story is that the usual hero of keto—ketone bodies like beta‑hydroxybutyrate—turns out not to be the main player here.

When the team cranked ketone production up or shut it down, tumor growth barely budged.

Instead, the real action was happening in how intestinal cells burned fat for fuel, a process called fatty acid oxidation.

That fat‑burning switch activated proteins known as PPARs, which pushed intestinal stem cells to divide faster.

More stem cells mean faster tissue repair, but they also mean more chances for something to mutate and turn cancerous.

A Direct Contradiction Of Earlier Research

This directly contradicts a prominent 2022 Nature paper that credited ketone bodies with protecting against colon cancer, and it exposes a core problem in the wellness world's love affair with keto.

"Diet" has been conflated with "metabolism" and "ketones" with "cancer protection," as if one molecule could neatly explain an entire disease process.

The new work suggests that it's the relentless high fat intake—not the ketones themselves—that is shaping cancer risk in this model, and that the story changes depending on which part of the gut you look at.

The Caveats Worth Knowing

Before anyone tries to turn this into a blunt weapon either for or against keto, there are important caveats.

These experiments were done in mice bred to develop intestinal tumors, similar to a rare human hereditary condition called familial adenomatous polyposis.

We do not yet know whether ordinary people on keto will see the same pattern, and the authors are clear that more research in humans is needed.

The study also hints that ketone supplements—so heavily pushed by the wellness industry—are unlikely to mimic either the risks or the benefits seen in these animals, because they don't reproduce the underlying fat metabolism that seems to matter most.

The Bigger Takeaway

What this study really challenges is the cultural momentum behind keto as a one‑size‑fits‑all "biohack."

When a diet can simultaneously suppress tumors in the colon and accelerate them in the small intestine, it's hard to argue that it is simply good or bad.

It forces a more uncomfortable but necessary conclusion: our bodies are complex, our cancers are diverse, and no trendy diet deserves blind faith.

Until we understand how extreme eating plans reshape the biology of different organs, treating keto like a disease‑proof lifestyle is not just naïve—it may be dangerously overconfident.